Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Li-Chen Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Daptomycin, Extracorporeal Membrane Oxygenation, Critical Illness, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Key R&D Program of China, Clinical Research Foundation of Shandong Province Medical Association, Medical and health technology development of Shandong Province.
Abstract (Originalsprache)
Background
Daptomycin is widely used in critically ill patients for Gram-positive bacterial infections. Extracorporeal membrane oxygenation (ECMO) is increasingly used in this population and can potentially alter the pharmacokinetic (PK) behaviour of antibiotics. However, the effect of ECMO has not been evaluated in daptomycin. Our study aims to explore the effect of ECMO on daptomycin in critically ill patients through population pharmacokinetic (PopPK) analysis and to determine optimal dosage regimens based on both efficacy and safety considerations.
Methods
A prospective, open-label PK study was carried out in critically ill patients with or without ECMO. The total concentration of daptomycin was determined by UPLC-MS/MS. NONMEM was used for PopPK analysis and Monte Carlo simulations.
Results
Two hundred and ninety-three plasma samples were collected from 36 critically ill patients, 24 of whom received ECMO support. A two-compartment model with first-order elimination can best describe the PK of daptomycin. Creatinine clearance (CLCR) significantly affects the clearance of daptomycin while ECMO has no significant effect on the PK parameters. Monte Carlo simulations showed that, when the MICs for bacteria are ≥1 mg/L, the currently recommended dosage regimen is insufficient for critically ill patients with CLCR > 30 mL/min. Our simulations suggest 10 mg/kg for patients with CLCR between 30 and 90 mL/min, and 12 mg/kg for patients with CLCR higher than 90 mL/min.
Conclusions
This is the first PopPK model of daptomycin in ECMO patients. Optimal dosage regimens considering efficacy, safety, and pathogens were provided for critical patients based on pharmacokinetic-pharmacodynamic analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China.
- Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, School of Pha…
- Department of Pharmacy, The Second Hospital, Shandong University, Jinan, China.
ORCID-Profile: Wei Zhao
Förderung
- National Key R&D Program of China
- Clinical Research Foundation of Shandong Province Medical Association
- Medical and health technology development of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, L. C., Li, Q. Y., Zhang, Y. Q., Shan, T. C., Li, Y., Li, Y. H., Han, H., Qin, W. D., Guo, H. P., Zhao, W., Tang, B. H., & Chen, X. M. (2024). Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae171
Vancouver
Zhang LC, Li QY, Zhang YQ, Shan TC, Li Y, Li YH, et al. Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae171
BibTeX
@article{Zhang2024,
author = {Zhang, Li-Chen and Li, Qiu-Yue and Zhang, Yu-Qiu and Shan, Ti-Chao and Li, Yuan and Li, Yi-Hui and Han, Hui and Qin, Wei-Dong and Guo, Hai-Peng and Zhao, Wei and Tang, Bo-Hao and Chen, Xiao-Mei},
title = {Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae171}
}
EUVIMED